• Dr. DB Recommends
  • NP Free Masterclass
  • Free Email Course
  • NP Book
  • Book Appointment
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
Positive ANA (anti nuclear antibody):  an Open Letter to Lady Gaga Offering a Solution

Positive ANA (anti nuclear antibody):  an Open Letter to Lady Gaga Offering a Solution

by Dr. David Bilstrom | Apr 28, 2023 | autoimmune disease, Lady Gaga, positive ANA

Hello Lady Gaga, I’m Dr. David Bilstrom. This is an open letter to you regarding your positive ANA. I’m a quadruple board certified medical doctor who specializes in reversing and preventing all autoimmune disease, with the goal of revolutionizing the way...
A Positive ANA is a New Autoimmune Disease (Bilstrom’s Nuclearitis)

A Positive ANA is a New Autoimmune Disease (Bilstrom’s Nuclearitis)

by Dr. David Bilstrom | Apr 25, 2023 | autoimmune disease, Bilstrom's Nuclearitis, positive ANA

AWhile it may seem weird to celebrate the announcement of a new autoimmune disease, if medicine doesn’t have a name for a disease, it doesn’t know what to do. Before Bilstrom’s Nuclearitis was named, allopathic medicine just called it a “positive ANA” and had no...
Return to STORE

Disclaimer: Please note, this website is not designed to provide any type of healthcare including diagnosing or treating any specific medical conditions. This website is intended for informational purposes only. If you are interested in becoming a patient, learn how to book appointment with Dr. David Bilstrom, Autoimmune Functional Medicine MD.

Dr David Bilstrom Autoimmune Functional Medicine Doctor Logo


help@drdavidbilstrom.com



866-623-1133

Site Navigation

Store

About

Blog

Resources

Contact

Site Legal Docs

Privacy Policy

Refunds and Cancellation

Site Map

Sign Up For Our Newsletter

Join thousands of people who have reversed their autoimmune and chronic disease using Dr. Bilstrom’s proven protocols. It’s free. No spam.

Click here to sign up today!

© 2025 Dr. David Bilstrom, All rights reserved | Website by Your Medical Liaison

  • Follow
  • Follow
  • Follow
  • Follow
  • Follow